January 2017

31 January 2017 Appendix 4C - Quarterly Cashflow Report

19 January 2017 Shareholder Update January 2017

12 January 2017 VivaGel® BV granted QIDP and Fast Track designation by US FDA

December 2016

22 December 2016 Starpharma receives $3.5M R&D tax incentive refund

November 2016

29 November 2016 AGM Chairman’s address and CEO presentation

28 November 2016 Starpharma signs license for VivaGel® Condom in Iran

October 2016

26 October 2016 Starpharma to present at US Drug Delivery Conference

25 October 2016 Starpharma to present at ASX Spotlight in Asia

13 October 2016 Enrolment complete for Phase 3 VivaGel® BV-R program

September 2016

13 September 2016 VivaGel® condom receives regulatory approval in Canada

August 2016

30 August 2016 Highlights of FY2016 Presentation: FNN Interview

29 August 2016 Annual Report and full year financial results